Brittney Ulness, PA
Physician Assistant · Sheboygan, WINPI 1942782818
Payments from drug & device makers
Across 1,021 payments — averaging $18.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$3K
- AbbVie$3K
- Johnson & Johnson$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Novartis$1K
- Lilly USA, LLC$1K
- plus $7K from 26 others
What the payments were for
- Consulting fees$1,6669%
- Food & beverage$16,61389%
- Education$4642%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 60 | $2,855 |
| AbbVie(2 entities) | 174 | $2,800 |
| Johnson & Johnson | 124 | $2,002 |
| Regeneron Healthcare Solutions, Inc. | 62 | $1,549 |
| Novartis | 81 | $1,191 |
| Lilly USA, LLC | 75 | $1,171 |
| Sun Pharmaceutical Industries Inc. | 72 | $1,008 |
| E.r. Squibb & Sons, L.L.C. | 75 | $991 |
| Sanofi | 47 | $914 |
| Amgen | 47 | $893 |
| Pfizer | 59 | $725 |
| Dermavant Sciences, Inc. | 27 | $491 |
| Incyte Corporation | 28 | $469 |
| LEO Pharma Inc. | 15 | $355 |
| Galderma Laboratories, L.p. | 15 | $321 |
| Arcutis Biotherapeutics, Inc. | 20 | $295 |
| VYNE Pharmaceuticals Inc. | 9 | $138 |
| Organon | 7 | $110 |
| Boehringer Ingelheim | 4 | $92 |
| Dermira, Inc. | 3 | $64 |
| ANI Pharmaceuticals, Inc. | 3 | $57 |
| Journey Medical Corporation | 2 | $41 |
| Biofrontera Inc. | 3 | $34 |
| Kyowa Kirin, Inc. | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Biocon Biologics Inc | 1 | $21 |
| Sandoz | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Celltrion USA Inc. | 1 | $18 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Botanix SB Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPIDUO FORTE$141
- AKLIEF$141
- ANZUPGO$112
- VTAMA$100
How this compares
$18,743 in reported general payments places this provider in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 28 | $387,251 |
| Dupixent PenDupilumab | 65 | $274,872 |
| TremfyaGuselkumab | 12 | $167,273 |
| Taltz AutoinjectorIxekizumab | 13 | $87,879 |
| OtezlaApremilast | 21 | $86,469 |
| XolairOmalizumab | 14 | $40,749 |
| Pimecrolimus | 22 | $6,904 |
| Clobetasol Propionate | 168 | $5,802 |
| Ketoconazole | 289 | $4,796 |
| Tacrolimus | 22 | $2,816 |
| Fluorouracil | 32 | $2,284 |
| Metronidazole | 33 | $2,153 |
| Clindamycin Phosphate | 50 | $1,886 |
| Tretinoin | 16 | $1,413 |
| Triamcinolone Acetonide | 172 | $1,206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonTremfya | $2,002 | $167,27312 claims |
| AmgenOtezla | $893 | $86,46921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,804 physician assistant providers in Wisconsin.
Other physician assistant in Sheboygan
- Sara HollandMadison$189K
- Lisa SershonMilwaukee$182K
- Sarah VicariFranklin$120K
- Jessica SzpakBaraboo$95K
- Amy BurmeschMenomonee Falls$79K
- Eric GoddeyneGreen Bay$61K
- Charnai SherryMilwaukee$45K
- Victoria MaloneyWauwatosa$28K
- Joseph FraneckiMilwaukee$27K
- Amanda SellFranklin$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.